Targeted and non-targeted polymer drug delivery systems

ACS Symposium Series

Volumn 923, Issue , 2006, Pages 137-154

  Thurmond II, K Bruce ^a   McEwan, John ^b   Moro, Dan G ^a   Rice, John R ^a   Russell Jones, Gregory ^b   St John, John V ^a   Sood, Paul ^a   Stewart, Donald R ^a   Nowotnik, David P ^a  

^a Access Pharmaceuticals Inc   (United States)

^b Access Pharmaceuticals Australia Pty Ltd   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33846386758     PISSN: 00976156     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (23)

1. Greenwald, R.B.; Zhao, H.; Xia, J.; Wu, D.; Nervi, S.; Stinson, S.F.; Majerova, E.; Bramhall, C.; Zaharevitz, D.W. Polyethylene glycol) prodrugs of the CDK inhibitor, alsterpaullone (NSC 705707): synthesis and pharmacokinetic studies. Bioconjugate Chem. 2004, 15, 1076-1083.
2. Duncan, R.; Gac-Breton, S.; Keane, R.; Musila, R.; Sat, Y.N.; Satchi, R.; Searle, F. Polymer-drug conjugates, PDEPT and PELT: basic principles for design and transfer from the lab to the clinic. J. Control. Rel. 2001, 74, 135-146.
3. Kopecek, J.; Kopeckova, P.; Minko, T.; Lu, Z.R.; Peterson, C.M. Water soluble polymers in tumor targeted delivery. J. Control. Rel. 2001, 74, 147-158.
4. Langer, C.J. CT-2103: emerging utility and therapy for solid tumors. Expert Opin. Investig. Drugs 2004, 13, 1501-1508.
5. Wang, D.; Li, W.; Pechar, M.; Kopeckova, P.; Bromine, D.; Kopecek, J. Cathepsin K inhibitor-polymer conjugates: potential drugs for the treatment of osteoporosis and rheumatoid arthritis. Int. J. of Pharma. 2004, 277, 73-79.
6. Rodriguez, G.; Gallardo, A.; Fernandez, M.; Rebuelta, M.; Bujan, J.; Bellon, J.M.; Honduvilla, N.G.; Escudero, C.; San Roman, J. Hydrophilic polymer drug from a derivative of salicylic acid: synthesis, controlled release studies and biological behavior. Macromol. Biosci. 2004, 4, 579-586.
7. Vasey, P.A.; Kaye, S.B.; Morrison, R.; Twelves, C.; Wilson, P.; Duncan, R.; Thomson, A.H.; Murray, L.S.; Hilditch, T.E.; Murray, T.; Burtles, S.; Fraier, D.; Frigerio, E.; Cassidy, J. Phase I Clinical and Pharmacokinetic Study of PK1 [N-(2-Hydroxypropyl)methacrylamide Copolymer Doxorubicin]: First Member of a New Class of Chemotherapeutic Agents-Drug-Polymer Conjugates. Clin. Cancer Res. 1999, 5, 83-94.
8. w) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats. J. Biomed. Mater. Res. 1987, 21, 1341-1358.
9. Avgoustakis, K.; Beletsi, A.; Panagi, Z.; Klepetsanis, P.; Karydas, A.G.; Ithakissios, D.S. PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J. Control. Rel. 2002, 79, 123-135.
10. Huang, G.; Gao, J.; Hu, Z.; St. John, J.V.; Ponder, B.C.; Moro, D. Controlled drug release from hydrogel nanoparticle networks. J. Control. Rel. 2004, 94, 303-311.
11. Kopecek, J.; Rejmanova, P.; Strohalm, J.; Ulbrich, K.; Rihova, B.; Chytry, V.; Lloyd, J.B.; Duncan, R. Synthetic polymeric drugs. U.S. Pat. 5,037,883, 1991.
12. Gianasi, E.; Buckley, R.G.; Latigo, J.; Wasil, M.; Duncan, R. HPMA Copolymer Platinates Containing Dicarboxylato Ligands. Preparation, Characterization, and In Vitro and In Vivo Evaluation. J. Drug Targeting 2002, 10, 549-556.
13. Stewart, D.R.; Rice, J.R. St. John, J.V. N,O-amidomalonate platinum complexes. U.S. Pat. 6,692,734, 2004.
14. 12. Bioconjugate Chem. 1999, 10, 1131-1136.
15. Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Rel. 2000, 65, 271-284.
16. Kissel, M.; Peschke, P.; Subr, V.; Ulbrich, K.; Schuhmacher, J.; Debus, J.; Friedrich, E. Synthetic Macromolecular Drug Carriers: Biodistribution of Poly[(N-2-hydroxypropyl)methacrylamide] Copolymers and Their Accumulation in Solid Rat Tumors. PDA J. of Pharma. Sci. & Tech. 2001, 55, 191-201.
17. Mishima, M.; Samimi, G.; Kondo, A.; Lin, X.; Howell, S.B. The cellular pharmacology of oxaliplatin resistance. Eur. J. Cancer 2002, 38, 1405-1412.
18. Russell-Jones, G.J. The potential use of receptor-mediated endocytosis for oral drug delivery. Adv. Drug Del. Rev. 2001, 47, 21-37.
19. Wang, S.; Low, P.S. Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells. J. Control. Rel. 1998, 53, 39-48.
20. Ramaswamy, K. Intestinal absorption of water soluble vitamins. Focus on molecular mechanism of the intestinal biotin transport process. Am. J. Physiol. 1999, 277, C603-604.
21. Hoffman, A.S. Hydrogels for biomedical applications. Adv. Drug Del. Rev. 2002, 43, 3-12.
22. Liu, Z.L.; Hu, H.; Zhuo, R.X. Konjac Glucomannan-graft-Acrylic Acid Hydrogels Containing Azo Crosslinker for Colon-Specific Delivery. J. Polym. Sci. Part A: Polym. Chem. 2004, 42, 4370-4378.
23. Orban, J.M.; Marra, K.G.; Hollinger, J.O. Composition Options for Tissue Engineered Bone. Tissue Eng. 2002, 8, 529-539.